Researcher
Sophie Van Welden
- Keywords:colorectal cancer, intestinal fibrosis, inflammatory bowel disease
- Disciplines:Gastro-enterology, Cancer biology
Affiliations
- Department of Internal Medicine and Pediatrics (Department)
Member
From1 Oct 2018 → Today - Department of Internal medicine (Department)
Member
From1 Feb 2012 → 30 Sep 2018
Projects
1 - 4 of 4
- MYCOLON - A mechanistic approach to map the interplay of mycotoxins and gut epithelium towards colorectal cancer riskFrom1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- MYCOLON - A mechanistic approach to map the interplay of mycotoxins and gut epithelium towards colorectal cancer riskFrom1 Nov 2023 → TodayFunding: FWO fellowships
- Hypoxia-induced signaling and its therapeutic implications for inflammatory bowel disease and colorectal cancerFrom1 Oct 2020 → TodayFunding: BOF - postdoctoral mandates
- The role of prolyl hydroxylase 1 in innate and adaptive immunity, therapeutic implications for inflammatory bowel disease?From1 Oct 2017 → 30 Sep 2020Funding: FWO fellowships
Publications
1 - 10 of 20
- Kupffer cells contested as early drivers in the pathogenesis of primary sclerosing cholangitis(2023)
Authors: Kevin De Muynck, Bart Vanderborght, Federico Francesco De Ponti, Eva Gijbels, Sophie Van Welden, Martin Guilliams, Charlotte Scott, Alain Beschin, Mathieu Vinken, Sander Lefere, et al.
Pages: 366 - 379 - MRI texture analysis of T2-weighted images is preferred over magnetization transfer imaging for readily longitudinal quantification of gut fibrosis(2023)
Authors: Simon Bos, Louke Delrue, Sophie Van Welden, Peter Bunyard, Pieter Hindryckx, Martine De Vos, Geert Villeirs, Debby Laukens
Pages: 5943 - 5952 - The quorum sensing peptide EntF* promotes colorectal cancer metastasis in mice : a new factor in the host-microbiome interaction(2022)
Authors: Evelien Wynendaele, Nathan Debunne, Anton De Spiegeleer, Frederick Verbeke, Liesa Tack, Sophie Van Welden, Evy Goossens, Daniel Knappe, Ralf Hoffmann, Debby Laukens, et al.
- Role of integrin expression in the prediction of response to vedolizumab : a prospective real‐life multicentre cohort study(2022)
Authors: Cara De Galan, Sophie Van Welden, Triana Lobatón Ortega, Wouter Van Moerkercke, Beatrijs Strubbe, Harald Peeters, Elisabeth Macken, Debby Laukens
- Long-term environmental hypoxia exposure and haematopoietic prolyl hydroxylase-1 deletion do not impact experimental Crohn's like ileitis(2021)
Authors: Cara De Galan, Debby Laukens, Sophie Van Welden
- Long-term environmental hypoxia does not impact experimental Crohn's like ileitis(2021)
Authors: Cara De Galan, Sophie Van Welden, Triana Lobatón Ortega, Pieter Hindryckx, Martine De Vos, Debby Laukens
Number of pages: 1 - Early prediction of response to vedolizumab in patients with active inflammatory bowel disease : a prospective real-life multicentre cohort study(2021)
Authors: Cara De Galan, Gerard Bryan Gonzales, Sophie Van Welden, Simon Tavernier, Triana Lobatón Ortega, Wouter Van Moerkercke, Beatrijs Strubbe, Harald Peeters, Elisabeth Macken, Martine De Vos, et al.
Number of pages: 1 - Integrin expression changes on the T cells subsets influence the response to vedolizumab in inflammatory bowel disease patients(2020)
Authors: Cara De Galan, Sophie Van Welden, Simon Bos, Triana Lobatón Ortega, Wouter Van Moerkercke, Beatrijs Strubbe, Harald Peeters, Elisabeth Macken, Debby Laukens
Number of pages: 1 - Integrin expression changes on the T cell subsets influence the response to vedolizumab in inflammatory bowel disease patients(2019)
Authors: Cara De Galan, Sophie Van Welden, Simon Bos, Triana Lobatón Ortega, Wouter Van Moerkercke, Beatrijs Strubbe, Harald Peeters, Elisabeth Macken, Debby Laukens
Number of pages: 1 - Intestinal hypoxia and hypoxia-induced signalling as therapeutic targets for IBD(2017)
Authors: Sophie Van Welden, Andrew C Selfridge
Pages: 596 - 611